MabThera (rituximab)

DRUG2 trials

Sponsors

University of Copenhagen, Gedeon Richter Plc.

Conditions

FatigueHyposalivationKeratoconjunctivitis SiccaPrimary Sjögren's SyndromeRheumatoid ArthritisXerostomia

Phase 1

Comparative Pharmacokinetic Trial of RGB-03 and MabThera

Gedeon Richter Plc.Rheumatoid Arthritis

Updated: 2015-02-25

Phase 2

Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome

CompletedNCT00426543

University of CopenhagenFatigue, Hyposalivation, Keratoconjunctivitis Sicca +2

Start: 2007-01-31End: 2010-08-31Updated: 2017-03-14